A British medical journalist offers a meticulously researched look at HIV and its potential source, discussing the history of this lethal epidemic, analyzing a number of theories concerning its origins, and investigating current scientific inquiries into HIV, AIDS, and the search for a cure. Reprint. 15,000 first printing.

Investigates the political and financial forces that have shaped AIDS research, including the growing dissension within scientific ranks, the power politics among virologists, and other controversial issues

Few people realize that the familiar HIV/AIDS global statistics are actually estimates. For example, UNAIDS estimated that the Republic of South Africa had 140,000 HIV/AIDS deaths in 1997. However, after tabulating all deaths for 1997, the Republic of South Africa attributed only 6,635 deaths to HIV/AIDS. Such discrepancies are rarely noted. The Republic of South Africa (RSA) stands as the exemplar of these discrepancies, and is reputed to have the world's largest AIDS epidemic with an estimated 5.6 million people living with HIV/AIDS (PLWH) in 2008. Such PLWH estimates, as with the estimates of HIV/AIDS deaths, are highly questionable. The reasons behind these discrepancies are clarified by describing two common misunderstandings of HIV infection that contribute to poor mathematical modeling outcomes. Unfortunately, the health authorities in the Republic of South Africa grant more validity to computer-generated estimates than to their own empirical death counts. The author discusses why these modeled estimates, and the HIV sero-prevalence surveys upon which they are based, are simply implausible. Presented with full references are raw numerical data on: the tabulated number of HIV/AIDS deaths in the RSA; the number of AIDS cases detected by RSA disease surveillance systems; UNAIDS/WHO estimates for AIDS deaths in the RSA; and UNAIDS/WHO estimates for the number of people living with HIV/AIDS in the RSA. The total cumulative HIV/AIDS cases in the United States and Africa are also presented for comparison, and to place the African and RSA data within appropriate epidemiological context. Overall, these data span from 1981 to 2009. Altogether, these data, plus additional information detailing the nature of HIV infection and heterosexual HIV transmission rates, explain why the hyperbolic mathematical estimates and HIV antibody test surveys - the primary sources of HIV/AIDS data in Africa - are simply implausible.

Examines conspiracy theories surrounding HIV and AIDS, focusing on two main widely believed falsehoods--that America manufactured AIDS to be a biological weapon and the belief that HIV is harmless and the true cause of AIDS are antiretroviral drugs.

A simple and authoritative challenge to the conventional wisdom about AIDS, this newly revised book probes widely held assumptions about the risks, tests, and treatments associated with this controversial disease. The ideas of the general public—that everyone is at risk, that AIDS is widespread, that HIV is proven to cause AIDS, and that drug treatments or vaccines offer the only hope to resolve health problems associated with AIDS—are refuted, and new information is presented on AIDS in Africa and recent research on the effects of AZT, protease inhibitors, and combo cocktails. A recommended reading list and website directory supply tools for further study, and first-person accounts from naturally healthy HIV-positive men, women, and children give the facts a human face.

During the early years of the AIDS epidemic, thousands of Americans became infected with HIV through the nation's blood supply. Because little reliable information existed at the time AIDS first began showing up in hemophiliacs and in others who had received transfusions, experts disagreed about whether blood and blood products could transmit the disease. During this period of great uncertainty, decision-making regarding the blood supply became increasingly difficult and fraught with risk. This volume provides a balanced inquiry into the blood safety controversy, which involves private sexual practices, personal tragedy for the victims of HIV/AIDS, and public confidence in America's blood services system. The book focuses on critical decisions as information about the danger to the blood supply emerged. The committee draws conclusions about what was doneâ€"and recommends what should be done to produce better outcomes in the face of future threats to blood safety. The committee frames its analysis around four critical area: Product treatmentâ€"Could effective methods for inactivating HIV in blood have been introduced sooner? Donor screening and referralâ€"including a review of screening to exlude high-risk individuals. Regulations and recall of contaminated bloodâ€"analyzing decisions by federal agencies and the private sector. Risk communicationâ€"examining whether infections could have been averted by better communication of the risks.